BridgeMD
New treatment option for Diabetic Foot Ulcer
Official title Diabetes Related Foot Ulcers With Negative Pressure Wound Therapy
ClinicalTrials.gov ID: NCT06721754
What this study is testing
- What it's testing
- The goal of this study is to learn if the clinical effects of Negative Pressure Wound Therapy (NPWT) is better, worse or the same as standard wound care for patients with diabetic foot ulcers (DFUs). The main questions it aims to answer are: Will there be a difference in the number of major amputations between the groups during the first year?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male and non-pregnant female above 18 years with a diabetic foot ulcer in need of surgical debridement or forefoot amputation
You likely can't join if
- Previous leg amputation due to diabetes
- Unable to ambulate on feet
- Unlikely to adhere to treatment and/or follow-up
- Unable to complete questionnaire
- Active or ongoing cancer treatment
- In need of amputation at a higher level than metatarsal or more than two metatarsals
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Nordbyhagen, Norway
- Grålum, Norway
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Nordbyhagen, Norway; Grålum, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.